Same-day Wellbutrin appointment in California

If you’re struggling with binge eating disorder (BED), you might be wondering whether you can access treatment through telehealth—without stepping foot in a doctor’s office. The short answer is yes. As of 2026, telehealth has become a legitimate, safe, and accessible pathway for getting evaluated and treated for BED using FDA-reviewed medications like Topamax (topiramate) and Wellbutrin (bupropion).

This guide walks you through everything you need to know: how telehealth prescribing laws work, which medications are available, who can prescribe them, and what to expect from your virtual visit.

Understanding Binge Eating Disorder and Why Treatment Matters

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of adults. It’s characterized by recurrent episodes of eating large quantities of food in a short period (typically within two hours), accompanied by a sense of loss of control. Unlike bulimia, BED doesn’t involve purging behaviors like vomiting or excessive exercise.

According to DSM-5 diagnostic criteria, BED involves:

• Eating an unusually large amount of food in a discrete period
• Feeling unable to control eating during these episodes
• Experiencing marked distress about the binge eating
• Binging at least once per week for three months
• No regular compensatory behaviors (purging, fasting, excessive exercise)

Left untreated, BED can lead to serious health complications including obesity, type 2 diabetes, cardiovascular disease, and mental health challenges like depression and anxiety. The good news? Effective treatments exist—and many are now accessible through telehealth.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Laws: What You Need to Know

Non-Controlled Medications Are Fully Accessible

Here’s the key detail that opens the door to telehealth BED treatment: Topamax and Wellbutrin are not controlled substances. This distinction is crucial because federal telehealth restrictions primarily apply to controlled medications (like ADHD stimulants or opioid painkillers) under the Ryan Haight Act.

For non-controlled prescription medications—which includes the primary medications used off-label for BED—there are no federal requirements for an in-person visit. Your healthcare provider can legally prescribe these medications after conducting a thorough telehealth evaluation.

Controlled Substance Rules (For Context)

While it doesn’t affect BED medications directly, it’s worth understanding the broader telehealth landscape. The DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2026. This means providers can still prescribe certain controlled medications via telehealth without an initial in-person visit—but stricter rules are expected once permanent regulations take effect.

The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a controlled stimulant. Due to tighter regulations around controlled substances, most reputable telehealth platforms focus on non-controlled alternatives like topiramate and bupropion instead.

State-by-State Telehealth Rules: Where Can You Get Treatment?

While federal law sets the baseline, individual states have their own telehealth regulations. The good news is that as of 2025-2026, the vast majority of states allow telehealth prescribing for non-controlled medications with minimal barriers.

States with No In-Person Requirements

California, New York, Texas, Florida, Michigan, Wisconsin, Delaware, and South Carolina all permit telehealth providers to prescribe medications like Topamax and Wellbutrin without requiring an in-person exam—as long as the provider conducts an appropriate evaluation via video or telehealth platform.

California even updated its laws in 2025 (AB 1503) to explicitly allow ‘asynchronous’ telehealth evaluations (like detailed online questionnaires) to count as a valid medical exam for prescribing non-controlled medications.

States with Periodic In-Person Follow-Up

A handful of states—including Alabama, Georgia, and New Hampshire—require patients receiving ongoing telehealth care to be seen in person at least once every 12 months. However, this in-person visit can often be completed with any licensed provider in your area (not necessarily the telehealth prescriber), and it typically only applies after multiple months of continuous treatment.

For example, in Alabama, if you’ve had more than four telehealth visits for the same condition within 12 months, state law requires an in-person evaluation within that year. But this can be satisfied by seeing a local primary care provider or collaborating physician.

Nurse Practitioners and Physician Assistants

Who can prescribe your BED medication via telehealth varies by state:

• 34 states plus DC now grant Nurse Practitioners (NPs) full practice authority, meaning they can evaluate, diagnose, and prescribe independently without physician oversight. Recent additions include Wisconsin, Michigan, Louisiana, and Kansas (all expanded NP scope in 2023-2025).

• In states like Texas, Florida, Georgia, and Alabama, NPs must work under a collaborative agreement with a physician. This doesn’t usually affect your care—it’s a behind-the-scenes requirement—but you may see both the NP’s and supervising physician’s names on your prescription.

• Physician Assistants (PAs) can prescribe non-controlled medications in all states, though most work under supervising physician agreements regardless of state.

The takeaway? Whether you’re seeing an MD, DO, NP, or PA via telehealth, you can receive appropriate BED treatment as long as they’re licensed in your state.

Medications for Binge Eating Disorder: What’s Available via Telehealth?

Topamax (Topiramate)

What it is: Originally FDA-approved for seizures and migraine prevention, topiramate has shown effectiveness in reducing binge eating episodes and supporting weight management when used off-label for BED.

How it works: Topiramate affects neurotransmitters in the brain that regulate appetite and impulse control. Research suggests it can help reduce binge frequency and obsessive thoughts about food.

Typical dosing: Providers usually start with a low dose (25mg daily) and gradually increase over several weeks to minimize side effects. Therapeutic doses for BED typically range from 50-200mg daily.

Important considerations:

• Pregnancy risk: Topiramate is linked to birth defects, particularly cleft palate, when taken during pregnancy. Your provider will likely require effective contraception if you’re of childbearing potential.
• Side effects: Common side effects include tingling in hands/feet, cognitive changes (difficulty finding words), carbonated beverages tasting flat, and weight loss.
• Gradual tapering: If you decide to stop topiramate, your provider will taper the dose gradually to prevent seizure risk.

Wellbutrin (Bupropion)

What it is: FDA-approved for depression and smoking cessation, bupropion has demonstrated effectiveness in reducing binge eating behaviors in clinical studies.

How it works: As an atypical antidepressant, bupropion affects dopamine and norepinephrine—brain chemicals involved in reward, motivation, and impulse control. This can help reduce the urge to binge.

Typical dosing: Starting doses are usually 150mg daily, potentially increasing to 300mg or 450mg daily depending on response and tolerability.

Important considerations:

• Black box warning: Like all antidepressants, bupropion carries a warning about increased suicidal thoughts in people under 25. Your provider will monitor you closely, especially in the first few weeks.
• Contraindications: Bupropion is contraindicated if you have a history of bulimia, anorexia nervosa, or seizure disorders due to increased seizure risk.
• Alcohol interaction: Avoid or strictly limit alcohol while taking bupropion, as it significantly increases seizure risk.
• Blood pressure monitoring: Bupropion can raise blood pressure, particularly when combined with other stimulating medications.

Off-Label Use: What Does It Mean?

Both medications are prescribed ‘off-label’ for BED—meaning the FDA hasn’t specifically approved them for this condition, though they’re approved for other uses. Off-label prescribing is completely legal and extremely common in medicine, especially in mental health and eating disorder treatment.

Clinical research supports using both medications for BED. Your telehealth provider should explain why they’re recommending a particular medication, discuss the evidence base, and obtain your informed consent for off-label use.

What to Expect from Your Telehealth Evaluation

The Initial Assessment

A legitimate telehealth evaluation for BED should be thorough and comprehensive—typically 30-45 minutes for your first visit. Your provider will ask detailed questions about:

• Eating patterns: Frequency of binge episodes, typical amounts consumed, triggers, time of day patterns
• Emotional relationship with food: Feelings of control, shame, distress around eating
• Mental health history: Depression, anxiety, trauma, other eating disorders
• Medical history: Current medications, chronic conditions, seizure history, pregnancy plans
• Previous treatments: What you’ve tried before (therapy, medications, programs)
• Safety screening: Suicidal thoughts, self-harm, substance use

Your provider will also verify that you meet DSM-5 diagnostic criteria for BED. Some platforms use standardized questionnaires like the Eating Disorder Examination Questionnaire (EDE-Q) or Binge Eating Scale (BES) to assess symptom severity.

Identity and Location Verification

Don’t be surprised when your telehealth provider verifies your identity and confirms your location at the start of your visit. This isn’t bureaucracy—it’s a legal requirement in many states to ensure the provider is licensed where you’re physically located and to prevent fraud.

Documentation and Informed Consent

Before prescribing, your provider will:

• Document that you meet diagnostic criteria for BED
• Explain the treatment plan, including medication options, expected benefits, and potential risks
• Obtain informed consent for telehealth treatment and off-label medication use
• Discuss alternatives, including psychotherapy and nutritional counseling
• Review potential side effects and safety monitoring plans

All of this goes into a secure electronic health record, just as it would in an in-person clinic.

What Disqualifies You from Telehealth Treatment?

Reputable providers screen for conditions that make online treatment inappropriate:

Absolute contraindications for specific medications:

• History of anorexia or bulimia (disqualifies bupropion due to seizure risk)
• Uncontrolled seizure disorder (limits both medications)
• Pregnancy or planning pregnancy (particularly for topiramate due to birth defect risk)
• Recent MAO inhibitor use (contraindicated with bupropion)

Situations requiring in-person evaluation:

• Severe medical instability (uncontrolled diabetes, very high blood pressure, cardiac issues)
• Acute suicidal ideation requiring immediate intervention
• Suspected neurological conditions needing physical examination
• Severe obesity with complications requiring in-person medical monitoring

If your situation requires more intensive care, a good telehealth provider will recognize this and help coordinate appropriate in-person resources.

Prescription Monitoring and Follow-Up Care

Prescription Drug Monitoring Programs (PMP)

Many states require providers to check the state Prescription Drug Monitoring Program database before prescribing controlled substances. Since Topamax and Wellbutrin aren’t controlled, most states don’t legally require a PMP check for these medications.

However, responsible providers may still review your prescription history as a safety precaution—for instance, to ensure you’re not already taking another form of bupropion or medications that could interact negatively.

Ongoing Monitoring Schedule

Because these are non-controlled medications, your provider can typically write prescriptions with refills for 3-6 months. However, regular follow-up appointments are essential, especially when starting treatment:

• First 2-4 weeks: Check-in to assess initial tolerance, side effects, and early response
• Months 1-3: Monthly visits to monitor effectiveness, adjust dosing, and track progress
• Ongoing: Every 1-3 months for continued monitoring, dose optimization, and treatment planning

Some states (like New Hampshire, Alabama, and Georgia) require at least one in-person follow-up visit within 12 months for ongoing telehealth treatment, though this can often be completed with any local provider.

Safety Monitoring

Your provider should track:

• Weight and vital signs: Especially important with topiramate (weight loss) and bupropion (blood pressure)
• Mental health status: Mood changes, suicidal thoughts (particularly with bupropion)
• Cognitive function: Memory, word-finding ability (can be affected by topiramate)
• Binge eating frequency: Using standardized scales or symptom diaries to measure improvement
• Side effects: Ongoing assessment of tolerability and quality of life

Good telehealth platforms provide secure messaging or nurse hotlines so you can report concerns between scheduled visits.

How Klarity Health Makes BED Treatment Accessible

Klarity Health specializes in connecting patients with licensed mental health providers for conditions like binge eating disorder—all through convenient telehealth visits.

What sets Klarity apart:

• Provider availability: Fast appointment scheduling with board-certified psychiatrists, psychiatric nurse practitioners, and therapists who specialize in eating disorders and related mental health conditions

• Transparent pricing: Clear, upfront costs with no hidden fees. Klarity accepts both insurance and self-pay options, making treatment accessible regardless of your coverage situation

• Comprehensive care: Klarity providers can prescribe medications like Topamax and Wellbutrin when clinically appropriate, and they also coordinate therapy referrals for the evidence-based counseling (like CBT) that’s crucial for long-term BED recovery

• State licensing: All Klarity providers are licensed in the states where they practice, ensuring full compliance with telehealth regulations

• Ongoing support: Regular follow-up visits, medication management, and care coordination—not just a one-time prescription

If you’re considering telehealth treatment for binge eating disorder, Klarity’s combination of clinical expertise, flexible scheduling, and insurance acceptance makes quality care more achievable.

Quality and Safety in Telehealth: Red Flags to Avoid

The telehealth boom brought increased access—but also some bad actors. Here’s how to identify legitimate providers:

Green Flags (Signs of Quality Care)

✅ Thorough initial evaluation (30+ minutes, detailed history-taking)
✅ Discussion of treatment alternatives (therapy, nutrition counseling, not just medication)
✅ Clear informed consent process explaining off-label use and risks
✅ Regular follow-up schedule with monitoring plans
✅ Transparent about what they don’t prescribe (e.g., controlled substances, medications outside scope)
✅ Licensed in your state with credentials you can verify
✅ Prescriptions sent to established pharmacies, not shipped directly from the company

Red Flags (Warning Signs)

🚩 Guaranteed prescription before evaluation (‘We’ll definitely prescribe what you want’)
🚩 Extremely brief ‘evaluation’ (5-10 minute questionnaire with immediate prescription)
🚩 No discussion of risks or alternatives
🚩 Starting multiple new medications simultaneously without clear rationale
🚩 Directly selling medication rather than using licensed pharmacies
🚩 No follow-up plan or difficulty reaching providers between visits
🚩 Unwillingness to coordinate with other providers or share medical records

Remember: The 2024 federal indictment of telehealth executives for unsafe ADHD stimulant prescribing serves as a cautionary tale. That case involved controlled substances and egregious practices, but it underscores why choosing reputable, established telehealth providers matters.

Insurance Coverage and Costs

Insurance Acceptance

Most major health insurance plans now cover telehealth visits at the same rate as in-person appointments—a policy many states made permanent after the pandemic. Medicare has also extended telehealth coverage through 2026 for mental health services.

When using insurance for telehealth BED treatment:

• Verify your provider is in-network (Klarity Health works with most major insurers)
• Understand your copay or coinsurance for psychiatry/mental health visits
• Check whether your plan requires prior authorization for certain medications
• Confirm your prescription drug coverage for Topamax and Wellbutrin (both are typically covered generics)

Self-Pay Options

If you’re paying out-of-pocket, telehealth is often more affordable than traditional psychiatry:

• Initial evaluations: Typically $199-$299
• Follow-up visits: Usually $99-$149
• Medications: Both topiramate and bupropion are available as generics for $10-$40/month at most pharmacies

Klarity Health offers competitive self-pay rates with transparent pricing—no surprise bills.

The Role of Therapy in BED Treatment

While medication can be helpful, evidence-based psychotherapy remains the gold standard for binge eating disorder. The most researched approach is Cognitive Behavioral Therapy (CBT), specifically adapted for eating disorders.

CBT for BED helps you:

• Identify triggers for binge eating
• Develop healthier coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns
• Build skills to prevent relapse

Other effective therapies include Dialectical Behavior Therapy (DBT), Interpersonal Therapy (IPT), and nutritional counseling with a registered dietitian specializing in eating disorders.

The best outcomes typically come from combining medication with therapy. Many telehealth platforms, including Klarity Health, can coordinate both psychiatric medication management and therapy referrals—giving you comprehensive care under one roof.

2025-2026 Regulatory Updates: What’s Changed?

The telehealth landscape continues to evolve. Here are the most recent developments:

Federal Changes

• DEA telehealth extension through December 31, 2026: The fourth extension of pandemic-era flexibilities for controlled substance prescribing, giving certainty through the end of 2026 while permanent rules are finalized
• Non-controlled medications unaffected: Federal policy continues to allow full telehealth access for medications like Topamax and Wellbutrin with no special restrictions

State-Level Updates

• Wisconsin and Michigan joined the full practice authority states for Nurse Practitioners in 2025, expanding independent prescribing
• New Hampshire SB 252 (effective August 2025) explicitly permits telehealth prescribing of Schedule II-IV medications with annual in-person follow-up
• California AB 1503 (2025) clarified that asynchronous telehealth evaluations meet the legal standard for prescribing non-controlled medications
• New York final rule (May 2025) requires in-person exams for new controlled substance prescriptions but doesn’t affect non-controlled medications
• Delaware SB 101 (July 2025) resolved conflicts around medication-assisted treatment for opioid use disorder via telemedicine

What to Watch

• Alabama and South Carolina continue discussing nurse practitioner full practice authority legislation, but changes haven’t been enacted yet
• The DEA’s final rule on permanent telehealth prescribing for controlled substances is expected by late 2026
• Some temporary state waivers may expire, though most states have codified pandemic-era telehealth flexibilities into permanent law

Taking the First Step: Starting Your Telehealth Journey

If you’re ready to explore treatment for binge eating disorder, here’s how to get started:

1. Research telehealth providers: Look for platforms with licensed providers in your state, transparent pricing, and positive patient reviews. Klarity Health specializes in mental health and eating disorder treatment with experienced providers nationwide.

2. Check your insurance: Contact your insurance company or use your provider’s insurance verification tool to understand coverage and costs.

3. Prepare for your evaluation: Write down your symptoms, eating patterns, previous treatments, current medications, and questions for your provider. Honest, detailed information leads to better care.

4. Schedule your appointment: Most telehealth platforms offer appointments within days, not weeks. Klarity Health often has same-week availability.

5. Set up for success: Find a private, quiet space for your video visit. Have your insurance card and pharmacy information ready.

6. Be open to comprehensive treatment: Ask about therapy referrals, nutritional counseling, and support groups in addition to medication. Recovery from BED works best with a multidisciplinary approach.

Frequently Asked Questions

Q: Will my telehealth provider have to report my eating disorder to anyone?
A: No. Your treatment is confidential under HIPAA, just like in-person care. Providers only report if there’s imminent danger to yourself or others, suspected child/elder abuse, or in rare legal circumstances—not simply for having an eating disorder diagnosis.

Q: Can I switch from in-person treatment to telehealth?
A: Absolutely. If you’re currently seeing a provider in person, you can often transition to telehealth visits with the same provider (if they offer it) or switch to a telehealth platform like Klarity Health. Your new provider will coordinate care and review your treatment history.

Q: What if the medication doesn’t work?
A: Your provider should schedule follow-ups to assess response. If one medication isn’t effective after an adequate trial (typically 8-12 weeks), they may adjust the dose, try the other medication, or consider combination approaches. Therapy remains crucial regardless of medication response.

Q: Are there any medications I can’t take with Topamax or Wellbutrin?
A: Yes. Important interactions include:

• Bupropion + MAO inhibitors (dangerous interaction—requires 14-day washout)
• Bupropion + other medications containing bupropion (risk of overdose)
• Topiramate + oral contraceptives (may reduce effectiveness—use backup contraception)
• Either medication + alcohol (increased seizure risk)Always provide a complete medication list to your provider.

Q: How long will I need to take medication for BED?
A: Treatment duration varies. Some people benefit from 6-12 months of medication combined with therapy, then taper off successfully. Others find longer-term treatment helpful. Your provider should regularly reassess the need for continued medication and work toward the minimum effective treatment.

Q: Will my employer know I’m receiving mental health treatment?
A: If you use employer-sponsored insurance, your employer receives a summary of claims but not specific diagnostic information. They won’t see ‘binge eating disorder’ specifically. If privacy is a major concern, self-pay options provide complete confidentiality.

Conclusion: Accessible, Legal, and Effective Care

Telehealth has fundamentally changed access to binge eating disorder treatment—and the changes are here to stay. With clear regulations now in place, experienced providers available nationwide, and evidence-based medications accessible online, there’s never been a better time to seek help.

Key takeaways:

• Non-controlled BED medications like Topamax and Wellbutrin are fully accessible via telehealth with no federal in-person requirement
• Most states allow telehealth prescribing with minimal barriers; a few require periodic in-person follow-ups
• Licensed psychiatrists, psychiatric nurse practitioners, and physician assistants can all prescribe these medications via telehealth
• Quality providers conduct thorough evaluations, discuss alternatives, monitor safety, and coordinate comprehensive care
• Combining medication with evidence-based therapy offers the best outcomes for lasting recovery

If you’re struggling with binge eating disorder, you don’t have to face it alone—and you don’t have to wait weeks for an in-person appointment. Platforms like Klarity Health connect you with experienced providers quickly, affordably, and conveniently, whether you have insurance or prefer self-pay.

Ready to take the first step? Visit Klarity Health to schedule a confidential evaluation with a licensed provider who specializes in eating disorders and mental health. With provider availability across multiple states, transparent pricing, and both medication management and therapy referrals, Klarity makes getting the comprehensive care you deserve simpler than ever.

Recovery from binge eating disorder is possible—and it starts with reaching out for help.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine. Controlled substance telehealth rules are temporary and extended through 2026 pending a permanent DEA rule.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Citations

1. U.S. Department of Health and Human Services. ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ HHS.gov Press Room, January 2026. www.hhs.gov

2. Sheppard, Mullin, Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Sheppard Health Law Blog, August 2025. www.sheppardhealthlaw.com

3. Center for Connected Health Policy. ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP Policy Database, November-December 2025. www.cchpca.org

4. Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Health Jobs Nationwide Blog, 2025. blog.healthjobsnationwide.com

5. U.S. Food and Drug Administration. ‘WELLBUTRIN (Bupropion Hydrochloride) Extended-Release Tablets.’ DailyMed, NIH, current label. dailymed.nlm.nih.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12